揭开心力衰竭风险和结果中的胆途径:系统性审查和元分析
Arveen Shokravi1, Yuchen Luo1, Simon W Rabkin2
1Department of Medicine, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
Biochimica et biophysica acta. Molecular basis of disease
|November 7, 2025
概括
胆的代谢物,如类胆,与心力衰竭风险的增加有关. 了解这些联系可能会揭示心力衰竭预防和治疗的新治疗点.
科学领域:
- 心血管研究研究心血管研究
- 代谢学 代谢学 代谢学
- 生物化学 生化学
背景情况:
- 调查循环中的胆代谢物与心力衰竭 (HF) 发展之间的联系.
- 探索酸丁胆 (PC),三甲基胺N氧化物 (TMAO),贝他因和二甲基甘氨酸 (DMG) 与高血压的相关性.
- 检查将这些代谢物连接到HF病变的潜在机制.
研究的目的:
- 系统地审查和元分析胆代谢物与心力衰竭之间的关系.
- 基于胆新陈代谢,识别潜在的治疗点,以治疗和预防高血压.
主要方法:
- 在MEDLINE,EMBASE和PubMed进行了系统的文献搜索.
- 分析了9项前性队列研究,涉及267569名参与者.
- 对协会进行元分析以确定危险比率 (HR) 和置信区间 (CI).
主要成果:
- 胆和酸丁胆 (PC) 水平升高与高血压发病率的增加显著相关 (HR分别为1.33和1.25).
- 在已确定的HF中,较高的贝他因水平与不良临床结果有关 (HR 1.15).
- 机制包括PC的水解到lysophosphatidylcholine,导致炎症和心肌细胞亡.
结论:
- 胆代谢物在心力衰竭的发展和进展中起着重要作用.
- 了解所涉及的代谢途径为HF治疗提供了新的治疗策略的潜力.
- Lysophosphatidylcholine acyltransferase 1 和其他途径代表了高频干预的有希望的目标.
相关概念视频
01:29Heart Failure II: Pathophysiology
695
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
695
01:17Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
902
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
902
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
333
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
333
01:30Heart Failure IV: Classification and Diagnostic Evaluation
305
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
305
01:27Heart Failure I: Introduction
671
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
671